# Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer

> **NCT00557362** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 120 (actual)

## Conditions studied

- Fungal Keratitis

## Interventions

- **DRUG:** Natamycin 5%
- **DRUG:** Voriconazole
- **PROCEDURE:** Corneal de-epithelialization

## Key facts

- **NCT ID:** NCT00557362
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2018-08-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00557362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00557362, "Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00557362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*